Compounds > 1-hydroxy-3-amino-2-pyrrolidone

1-hydroxy-3-amino-2-pyrrolidone and dihydroxyphenylalanine

1-hydroxy-3-amino-2-pyrrolidone has been researched along with dihydroxyphenylalanine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Waldmeier, PC1
Bristow, LJ; Hutson, PH; Thorn, L; Tricklebank, MD1

Other Studies

2 other study(ies) available for 1-hydroxy-3-amino-2-pyrrolidone and dihydroxyphenylalanine

ArticleYear
The GABAB antagonist, CGP 35348, antagonizes the effects of baclofen, gamma-butyrolactone and HA 966 on rat striatal dopamine synthesis.
    Naunyn-Schmiedeberg's archives of pharmacology, 1991, Volume: 343, Issue:2

    Topics: 4-Butyrolactone; Animals; Baclofen; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; GABA-A Receptor Antagonists; Haloperidol; Organophosphorus Compounds; Pyrrolidinones; Rats; Tetrabenazine

1991
R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine.
    British journal of pharmacology, 1991, Volume: 103, Issue:4

    Topics: Amphetamine; Animals; Behavior, Animal; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Glycine; Locomotion; Male; Mice; Mice, Inbred Strains; Nucleus Accumbens; Pyrrolidinones; Rats; Rats, Inbred Strains; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter

1991